Attention-Deficit/Hyperactivity Disorder (ADHD) is typically conceptualized as a neurodevelopmental condition marked by persistent inattention, hyperactivity, and impulsivity. While cognitive and neurochemical models have advanced understanding and treatment, they do not fully explain the marked variability in symptom expression, emotional dysregulation, or inconsistent treatment outcomes. Emerging evidence suggests that biological responses to chronic stress may play a meaningful role in these patterns. Drawing on psychoneuroimmunology (PNI), this thesis examines how chronic stress–related immune activation interacts with dopaminergic systems implicated in ADHD. Particular focus is placed on hypothalamic–pituitary–adrenal (HPA) axis dysregulation, altered diurnal cortisol secretion, and elevations in pro-inflammatory cytokines such as IL-6, TNF-α, and CRP. These pathways may disrupt prefrontal and striatal dopamine signaling, contributing to attentional difficulties and emotional dysregulation. Integrating current evidence from stress physiology, neuroimmunology, and dopamine research, this work proposes that ADHD can be understood, in part, as a pattern of allostatic dysregulation, in which chronic stress and low-grade inflammation reinforce neural vulnerability. This perspective highlights the relevance of neuroimmune markers for explaining symptom heterogeneity and suggests potential benefit in extending ADHD management to include approaches that target stress regulation and inflammatory processes.

Attention-Deficit/Hyperactivity Disorder (ADHD) is typically conceptualized as a neurodevelopmental condition marked by persistent inattention, hyperactivity, and impulsivity. While cognitive and neurochemical models have advanced understanding and treatment, they do not fully explain the marked variability in symptom expression, emotional dysregulation, or inconsistent treatment outcomes. Emerging evidence suggests that biological responses to chronic stress may play a meaningful role in these patterns. Drawing on psychoneuroimmunology (PNI), this thesis examines how chronic stress–related immune activation interacts with dopaminergic systems implicated in ADHD. Particular focus is placed on hypothalamic–pituitary–adrenal (HPA) axis dysregulation, altered diurnal cortisol secretion, and elevations in pro-inflammatory cytokines such as IL-6, TNF-α, and CRP. These pathways may disrupt prefrontal and striatal dopamine signaling, contributing to attentional difficulties and emotional dysregulation. Integrating current evidence from stress physiology, neuroimmunology, and dopamine research, this work proposes that ADHD can be understood, in part, as a pattern of allostatic dysregulation, in which chronic stress and low-grade inflammation reinforce neural vulnerability. This perspective highlights the relevance of neuroimmune markers for explaining symptom heterogeneity and suggests potential benefit in extending ADHD management to include approaches that target stress regulation and inflammatory processes.

ADHD from a Psychoneuroimmunology Perspective: The Role of Chronic Stress and Neuroinflammation

GITETE, EMMANUEL
2024/2025

Abstract

Attention-Deficit/Hyperactivity Disorder (ADHD) is typically conceptualized as a neurodevelopmental condition marked by persistent inattention, hyperactivity, and impulsivity. While cognitive and neurochemical models have advanced understanding and treatment, they do not fully explain the marked variability in symptom expression, emotional dysregulation, or inconsistent treatment outcomes. Emerging evidence suggests that biological responses to chronic stress may play a meaningful role in these patterns. Drawing on psychoneuroimmunology (PNI), this thesis examines how chronic stress–related immune activation interacts with dopaminergic systems implicated in ADHD. Particular focus is placed on hypothalamic–pituitary–adrenal (HPA) axis dysregulation, altered diurnal cortisol secretion, and elevations in pro-inflammatory cytokines such as IL-6, TNF-α, and CRP. These pathways may disrupt prefrontal and striatal dopamine signaling, contributing to attentional difficulties and emotional dysregulation. Integrating current evidence from stress physiology, neuroimmunology, and dopamine research, this work proposes that ADHD can be understood, in part, as a pattern of allostatic dysregulation, in which chronic stress and low-grade inflammation reinforce neural vulnerability. This perspective highlights the relevance of neuroimmune markers for explaining symptom heterogeneity and suggests potential benefit in extending ADHD management to include approaches that target stress regulation and inflammatory processes.
2024
ADHD from a Psychoneuroimmunology Perspective: The Role of Chronic Stress and Neuroinflammation
Attention-Deficit/Hyperactivity Disorder (ADHD) is typically conceptualized as a neurodevelopmental condition marked by persistent inattention, hyperactivity, and impulsivity. While cognitive and neurochemical models have advanced understanding and treatment, they do not fully explain the marked variability in symptom expression, emotional dysregulation, or inconsistent treatment outcomes. Emerging evidence suggests that biological responses to chronic stress may play a meaningful role in these patterns. Drawing on psychoneuroimmunology (PNI), this thesis examines how chronic stress–related immune activation interacts with dopaminergic systems implicated in ADHD. Particular focus is placed on hypothalamic–pituitary–adrenal (HPA) axis dysregulation, altered diurnal cortisol secretion, and elevations in pro-inflammatory cytokines such as IL-6, TNF-α, and CRP. These pathways may disrupt prefrontal and striatal dopamine signaling, contributing to attentional difficulties and emotional dysregulation. Integrating current evidence from stress physiology, neuroimmunology, and dopamine research, this work proposes that ADHD can be understood, in part, as a pattern of allostatic dysregulation, in which chronic stress and low-grade inflammation reinforce neural vulnerability. This perspective highlights the relevance of neuroimmune markers for explaining symptom heterogeneity and suggests potential benefit in extending ADHD management to include approaches that target stress regulation and inflammatory processes.
PNI
Chronic Stress
Neuroinflammation
ADHD
Cortisol
File in questo prodotto:
File Dimensione Formato  
Final Dissertation Emmanuel.pdf

accesso aperto

Dimensione 723.52 kB
Formato Adobe PDF
723.52 kB Adobe PDF Visualizza/Apri

The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12608/101655